The inhibition of LAL as a potential strategy to reduce tumor growth could be used as a therapeutic development, however, the enzyme plays a critical role in regulating fatty acid metabolism as the KO of the gene results in severe dysregulation of energy homeostasis in mice (41) and humans with LAL mutations often suffer from lethality at a young age (42, 43). This evidence concerns the gene LIPA and neoplasm.